These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1432 related items for PubMed ID: 11499864

  • 1. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [Abstract] [Full Text] [Related]

  • 3. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 4. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 5. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
    Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM.
    J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778
    [Abstract] [Full Text] [Related]

  • 6. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [Abstract] [Full Text] [Related]

  • 7. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797
    [Abstract] [Full Text] [Related]

  • 8. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep 07; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 07; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 10. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep 07; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 11. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 12. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene.
    Bashir A, Mak YT, Sankaralingam S, Cheung J, McGowan NW, Grigoriadis AE, Fogelman I, Hampson G.
    Steroids; 2005 Dec 01; 70(13):847-55. PubMed ID: 16005483
    [Abstract] [Full Text] [Related]

  • 13. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
    Tian QX, Huang GY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug 01; 26(4):418-22. PubMed ID: 15379268
    [Abstract] [Full Text] [Related]

  • 14. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
    Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S.
    Biochem Biophys Res Commun; 2001 Jan 12; 280(1):334-9. PubMed ID: 11162519
    [Abstract] [Full Text] [Related]

  • 15. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B, Rader CP, Seufert J, Nöth U, Rolf O, Eulert J, Jakob F.
    Acta Orthop Scand; 2004 Jun 12; 75(3):295-302. PubMed ID: 15260421
    [Abstract] [Full Text] [Related]

  • 16. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 12; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 17. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.
    Carda C, Silvestrini G, Gomez de Ferraris ME, Peydró A, Bonucci E.
    Tissue Cell; 2005 Jun 12; 37(3):247-55. PubMed ID: 15899507
    [Abstract] [Full Text] [Related]

  • 18. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 12; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 19. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
    Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE.
    J Cell Biochem; 2002 Feb 12; 86(4):642-50. PubMed ID: 12210731
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.
    Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL.
    Bone; 2004 Jul 12; 35(1):334-42. PubMed ID: 15207775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.